Trials / Unknown
UnknownNCT04164433
Workplace-based HIV Self-testing Among Men in Uganda (WISe-Men)
Workplace-based HIV Self-testing (HIVST) and Linkage to Care or Prevention Services Among Men in Private Security Services in Uganda: A Cluster Randomized Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 548 (estimated)
- Sponsor
- Makerere University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study seeks to determine whether workplace delivery of HIV self-testing will lead to an increase in uptake of HIV testing and subsequent linkage to care or prevention services among men in Uganda.
Detailed description
The current coverage of HIV testing and counseling in Uganda is 60% with only 34% of these being men and only about 55% of males living with HIV know their status (MoH, 2016). The challenges with HIV testing require a new focus and new approaches to reach people with undiagnosed HIV infection. HIV self-testing (HIVST) is one such innovative approach to making testing more accessible to several under-served populations such as men and key populations (WHO, 2013). In this regard, this study seeks to determine whether providing HIVST in workplace settings will increase the uptake of HIV testing services among men employed in private security services in Uganda and improve linkage to treatment and prevention services. Design: Cluster randomized trial in two Ugandan districts Participants: Male employees of private security companies
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Oral HIV Self-Test (OraQuick) | The oral HIV self-test is a device for taking a test which is painless. The user gently swipes the test swab along the upper gums once and the lower gums once. The swab is then inserted inside the test tube provided and results are ready in 20 minutes. |
Timeline
- Start date
- 2020-02-01
- Primary completion
- 2020-12-05
- Completion
- 2021-01-31
- First posted
- 2019-11-15
- Last updated
- 2020-09-16
Locations
2 sites across 1 country: Uganda
Source: ClinicalTrials.gov record NCT04164433. Inclusion in this directory is not an endorsement.